"The Livingston Center believes that mental attitude can have a profound impact on the effective treatment and continued good health of a patient," explains clinical director and staff psychologist Robert Barrett, Ph.D.
Further, Dr. Livingston claimed that the cancer microbe is present inside sperm cells and, at conception, it releases the CG hormone to protect the fertilized egg. It does this because otherwise at least half of fetal cells would be regarded by the body as foreign and it would seek to destroy them. With this new biological understanding of the cancer process, Dr. Livingston went on to develop a practical, nontoxic approach. In general, she ruled out surgery because it would be impossible to remove all cancerous tissues as the disease is systemic. Also, "extensive mutilating surgery" would help spread the cancer by shocking the adrenal glands and further weakening the immune system which would now have to aid the body in healing from the surgery in addition to continuing to resist the cancer. However, Dr. Livingston advised having surgery to remove the tumor load if it could be easily removed without mutilation of the patient. A better approach, she proposed, would be to support the immune system, increase the body's resistance, and suppress the specific cancer microbe by eliminating the internal bodily conditions that enable it to thrive. A prime way to accomplish this, said Dr. Livingston, is through the use of specifically targeted vaccines, especially one prepared and precisely tailored from the patient's own P. cryptocides. Such a vaccine focuses on more than cancer-it addresses the entire immune system. This perspective came in handy in the late 1960s when an FDA official told Dr. Livingston she could not treat cancer with vaccines. "I assured him I was not treating cancer with vaccines but that I am using autogenous ['self-made,' from the patient's own cultured P. cryptocides] vaccines obtained from the patient's own tissues and bodily fluids to treat an underlying chronic infection." |
A vaccine is a preparation containing a weakened (attenuated) or "killed" solution of a specific bacterium, virus, or germ believed to produce a disease. After it is injected into the body, the immune system wages a protective response, developing antibodies to the disease-organism's foreign proteins. The theory is that the antibodies "remember" how to respond and neutralize the vaccine antigen in the future, thereby bestowing immunity to this illness. The word vaccine derives from vacca, which is Latin for "cow," because the first vaccination in 1796 was for cowpox. An antigen is any biological substance (a toxin, virus, fungus, bacterium, ameba, or other protein) that the body comes to regard as foreign and dangerous to itself. As such, an antigen induces a state of cellular sensitivity or immune reaction that seeks to neutralize, remove or destroy the antigen by dispatching antibodies against it. An immunoglobulin is one of a class of five antibody proteins produced in the spleen, bone marrow, or lymph tissue and involved in the immune system's defense response to foreign substances. The main types of immunoglobulins grouped according to their concentration in the blood, are: IgG (80%), IgA (10-15%), IgM (5-10%), IgD (less than 0. 1%), IgE (less than 0.01%). Technically, all antibodies are immunoglobulins.
|
It's no different in 1997, says the Center's medical
director, Mark H. LaBeau, D.O. The Center bills itself as specializing in the treatment of
"immunodeficiency" diseases. As it turns out, about 95% of their patients are
people with cancer. "We work with people and their weakened immune systems," he
says. The Livingston approach consists of multiple vaccines, dietary and nutritional
programs, and psychological counseling. According to Dr. LaBeau, among the cancer cases,
the Center tends to get the best results with cancers of the breast, prostate, colon, and
lymph system. Immunotherapy Based on Vaccines This phase of the Livingston program consists of six vaccines, several of them patented by Dr. Livingston. Their purpose is to stimulate production of antibodies to control the spread of P. cryptocides, raise the white blood cell count and disease-resisting potential of patients, stimulate key immune system cells (natural killer and B cells), and support the immune system in functioning more efficiently, says Dr. LaBeau. "Dr. Livingston found that when you use these six vaccines together you get a compounding effect and better results." Vaccine A-Here the cancer microbe itself is collected from the patient's own P.cryptocides, cultured overnight at room temperature in the laboratory, then filtered, concentrated, and injected into the muscle as a vaccine. The purified bacteria acts as an irritant (antigen) that provokes the immune system to respond to it and produce antibodies (specialized defense proteins) against it. Vaccine B-This vaccine is prepared and purified from "killed" (sterilized) bacteria cultured from the P. cryptocides, of a patient who has successfully overcome the cancer microbe. BCG Vaccine-The Bacillus Calmette-Guerin uses highly weakened tuberculosis (TB) microbes to evoke a strong immune response against cancer. The BCG vaccine has been commonly used against TB since its introduction in 1921. BCG is effective against cancer (as a "protective" factor) because Dr. Livingston's research showed that its structure is highly similar to that of P. cryptocides. "When the immune system is stimulated with BCG to react to tuberculosis bacteria, it is also stimulated to cross-react to P. cryptocides," says Dr. LaBeau.
|
